id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-1210-0003,FDA,FDA-2014-N-1210,"Reference 1 - The Practice of Electroconvulsive Therapy - Recommendations for Treatment, Training and Privileging",Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:24:31Z,,0,0,0900006481dd8bf6
FDA-2014-N-1210-0009,FDA,FDA-2014-N-1210,Reference 7 - Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-Analysis,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:23:16Z,,0,0,0900006481dd8c8e
FDA-2014-N-1210-0011,FDA,FDA-2014-N-1210,Reference 9 - An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:22:54Z,,0,0,0900006481dd8e03
FDA-2014-N-1210-0006,FDA,FDA-2014-N-1210,Reference 4 - Mental Health - A Report of the Surgeon General,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:23:50Z,,0,0,0900006481dd8c8b
FDA-2014-N-1210-0004,FDA,FDA-2014-N-1210,Reference 2 - Guidance on the Use of Electroconvulsive Therapy,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:24:16Z,,0,0,0900006481dd8bfa
FDA-2014-N-1210-0008,FDA,FDA-2014-N-1210,"Reference 6 - Clinical and Cost-Effectiveness of Electroconvulsive Therapy for Depressive Illness, Schizophrenia, Catatonia and Mania-Systematic Reviews and Economic Modelling Studies",Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:23:27Z,,0,0,0900006481dd8c8d
FDA-2014-N-1210-0007,FDA,FDA-2014-N-1210,Reference 5 - Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression- A Systematic Review and Meta-Analysis,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:23:38Z,,0,0,0900006481dd8c8c
FDA-2014-N-1210-0010,FDA,FDA-2014-N-1210,Reference 8 - Initial Severity and Antidepressant Benefits- A Meta-Analysis of Data Submitted to the Food and Drug Administration,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:23:04Z,,0,0,0900006481dd8e02
FDA-2014-N-1210-0002,FDA,FDA-2014-N-1210,List of References for Reclassification of Electroconvulsive Therapy (ECT) Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for ECT Devices for Certain Specified Intended Uses Proposed Order,Supporting & Related Material,List,2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:24:43Z,,0,0,0900006481dd8bf5
FDA-2014-N-1210-0005,FDA,FDA-2014-N-1210,Reference 3 - Depression in Adults - The Treatment and Management of Depression in Adults,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:24:01Z,,0,0,0900006481dd8bfb
FDA-2014-N-1210-0001,FDA,FDA-2014-N-1210,Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who Are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy for Certain Specified Intended Uses,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2015-12-29T05:00:00Z,2015,12,2015-12-29T05:00:00Z,2016-03-29T03:59:59Z,2019-01-14T20:50:27Z,2015-32592,0,0,0900006481dd79bf
FDA-2014-N-1210-0012,FDA,FDA-2014-N-1210,Reference 10 - Electroconvulsive Therapy in Lorazepam Non-Responsive Catatonia,Supporting & Related Material,Reference (external attachments),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:22:43Z,,0,0,0900006481dd8e0a
FDA-2014-N-1210-0013,FDA,FDA-2014-N-1210,"Reference 11 - FDA Executive Summary - Prepared for the March 17, 2011 Meeting of the Neurologic Devices Panel",Supporting & Related Material,Reference (internal unless indicated),2015-12-29T05:00:00Z,2015,12,,,2015-12-29T17:22:32Z,,0,0,0900006481dd8e0b